- Home
- APCX vs ICU Comparison
APCX vs ICU Comparison
Compare APCX & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APCX
- ICU
- Stock Information
- Founded
- APCX 2006
- ICU 2018
- Country
- APCX United States
- ICU United States
- Employees
- APCX N/A
- ICU N/A
- Industry
- APCX Finance: Consumer Services
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- APCX Finance
- ICU Health Care
- Exchange
- APCX Nasdaq
- ICU Nasdaq
- Market Cap
- APCX 12.0M
- ICU 10.4M
- IPO Year
- APCX N/A
- ICU N/A
- Fundamental
- Price
- APCX $0.29
- ICU $1.26
- Analyst Decision
- APCX
- ICU
- Analyst Count
- APCX 0
- ICU 0
- Target Price
- APCX N/A
- ICU N/A
- AVG Volume (30 Days)
- APCX 176.2K
- ICU 198.0K
- Earning Date
- APCX 05-13-2025
- ICU 05-13-2025
- Dividend Yield
- APCX N/A
- ICU N/A
- EPS Growth
- APCX N/A
- ICU N/A
- EPS
- APCX N/A
- ICU N/A
- Revenue
- APCX $276,000.00
- ICU $135,000.00
- Revenue This Year
- APCX N/A
- ICU $648.15
- Revenue Next Year
- APCX N/A
- ICU $100.00
- P/E Ratio
- APCX N/A
- ICU N/A
- Revenue Growth
- APCX N/A
- ICU N/A
- 52 Week Low
- APCX $0.31
- ICU $1.11
- 52 Week High
- APCX $1.49
- ICU $14.98
- Technical
- Relative Strength Index (RSI)
- APCX 36.05
- ICU 35.62
- Support Level
- APCX $0.24
- ICU $1.15
- Resistance Level
- APCX $0.42
- ICU $1.35
- Average True Range (ATR)
- APCX 0.04
- ICU 0.12
- MACD
- APCX -0.00
- ICU 0.01
- Stochastic Oscillator
- APCX 26.44
- ICU 41.67
About APCX AppTech Payments Corp.
AppTech Payments Corp is a FinTech company utilizing various payment processing and digital banking technologies to complement core merchant services capabilities. The company's patented and proprietary software will provide progressive and adaptable products that are available through a suite of synergistic offerings directly to merchants, banking institutions, and business enterprises. It is developing a secure digital payment and banking platform that powers commerce experiences for clients and customers. Based upon industry standards for payment and banking protocols, the company will offer standalone products and fully integrated solutions that deliver unparalleled payments, banking, and financial services experiences.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.